Effect of Methadone Dose on Maintenance Treatment and Health Consequences Among Heroin Addicts in South China

REFERENCES

• Anglin, M. D., Conner, B. T., Annon, J. J., & Longshore, D. (2009). Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior. Journal of Behavioral Health Services & Research, 36(2), 267–282. doi: 10.1007/s11414-008-9155-x
   PubMedGoogle Scholar
• Baker, A., Kochan, N., Dixon, J., Wodak, A., & Heather, N. (1995). HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction, 90(4), 545–554.
   PubMedGoogle Scholar
• Bao, Y. P., Liu, Z. M., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. American Journal of Drug and Alcohol Abuse, 35(1), 28–33. doi: 907874089 [pii]10.1080/00952990802342899
   PubMed Web of Science ®Google Scholar
• Blaney, T., & Craig, R. J. (1999). Methadone maintenance. Does dose determine differences in outcome? Journal of Substance Abuse Treatment, 16(3), 221–228. doi: S0740-5472(98)00031-2 [pii]
   PubMed Web of Science ®Google Scholar
• Brady, T. M., Salvucci, S., Sverdlov, L. S., Male, A., Kyeyune, H., Sikali, E., (2005). Methadone dosage and retention: an examination of the 60 mg/day threshold. Journal of Addictive Diseases, 24(3), 23–47.
   PubMed Web of Science ®Google Scholar
• Bux, D. A., Lamb, R. J., & Iguchi, M. Y. (1995). Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend, 37(1), 29–35. doi: 037687169401058S [pii]
   PubMed Web of Science ®Google Scholar
• California Society of Addiction Medicine (2009). Guidelines for physicians working in California Opioid Treatment Programs. Retrieved March 13, 2013, from http://www.csamasam.org/ pdf/misc/CSAM_OTPGuideline_-_Round_3-16Oct08.pdf
   Google Scholar
• Chu, T. X., & Levy, J. A. (2005). Injection drug use and HIV/AIDS transmission in China. [Research Support, NI.H., . Extramural Review]. Cell Research, 15(11-12), 865–869. doi: 10.1038/sj.cr.7290360
   PubMed Web of Science ®Google Scholar
• Darke, S. (1998). Self-report among injecting drug users: A review. Drug Alcohol Dependence, 51(3), 253–263; discussion 267–258. doi: S0376871698000283 [pii]
   PubMed Web of Science ®Google Scholar
• Darke, S., Hall, W., Heather, N., Ward, J., & Wodak, A. (1991). The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS, 5(2), 181–185.
   PubMed Web of Science ®Google Scholar
• Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic blockade. Archives of Internal Medicine, 118(4), 304–309.
   PubMed Web of Science ®Google Scholar
• Donny, E. C., Brasser, S. M., Bigelow, G. E., Stitzer, M. L., & Walsh, S. L. (2005). Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction, 100(10), 1496–1509. doi: ADD1232 [pii]10.1111/j.1360-0443.2005.01232.x
   PubMed Web of Science ®Google Scholar
• Donny, E. C., Walsh, S. L., Bigelow, G. E., Eissenberg, T., & Stitzer, M. L. (2002). High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl), 161(2), 202–212. doi: 10.1007/s00213-002-1027-0
   PubMed Web of Science ®Google Scholar
• Fareed, A., Casarella, J., Amar, R., Vayalapalli, S., & Drexler, K. (2010). Methadone maintenance dosing guideline for opioid dependence—A literature review. Journal of Addictive Diseases, 29(1), 1–14. doi: 918588494 [pii]10.1080/10550880 903436010
   PubMed Web of Science ®Google Scholar
• Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., (1998). Cross-validation of item selection and scoring for the SF-12 Health survey in nine countries: Results from the IQOLA project, International Quality of Life Assessment. Journal of Clinical Epidemiology, 51(11), 1171–1178. doi: S0895435698001097 [pii]
   PubMed Web of Science ®Google Scholar
• Gibson, D. R., Flynn, N. M., & McCarthy, J. J. (1999). Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 13(14), 1807–1818.
   PubMed Web of Science ®Google Scholar
• Hartel, D. M., & Schoenbaum, E. E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Report, 113( Suppl 1), 107–115.
   PubMedGoogle Scholar
• Hutchinson, M. K., & Holtman, M. C. (2005). Focus on research methods: Analysis of count data using Poisson regression. Research in Nursing & Health, 28, 408–418.
   PubMed Web of Science ®Google Scholar
• Li, L., Wang, H. M., & Shen, Y. (2003). Chinese SF-36 health survey: translation, cultural adaptation, validation, and normalisation. Journal of Epidemiology and Community Health , 57(4), 259–263.
   PubMed Web of Science ®Google Scholar
• Loimer, N., & Schmid, R. (1992). The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Dependence, 30(3), 241–246.
   PubMed Web of Science ®Google Scholar
• Maxwell, S., & Shinderman, M. S. (2002). Optimizing long-term response to methadone maintenance treatment: A 152-week follow-up using higher-dose methadone. Journal of Addictive Diseases, 21(3), 1–12.
   PubMed Web of Science ®Google Scholar
• McHorney, C. A., Ware, J. E., Jr., Lu, J. F., & Sherbourne, C. D. (1994). The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32(1), 40–66.
   PubMed Web of Science ®Google Scholar
• Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome, 6(9), 1049–1056.
   PubMed Web of Science ®Google Scholar
• Mino, A., Page, D., Dumont, P., & Broers, B. (1998). Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva. Drug Alcohol Dependence, 50(3), 233–239. doi: S0376871698000350 [pii]
   PubMed Web of Science ®Google Scholar
• Ministry of Health. (2011). China's HIV epidemic 2011. Retrieved March 13, 2013, from http: //www.moh.gov.cn/publicfiles/// business/cmsresources/mohyzs/cmsrsdocument/doc13944.pdf
   Google Scholar
• Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985–1990. AIDS, 8(2), 223-231.
   Google Scholar
• National Center for AIDS/STD Control and Prevention. (2006). The national methadonetreatment clinical guide. Beijing: Chinese Centre of Disease Control and Prevention. Retrieved March 13, 2013, from http://www.chinaaids.cn/ chinammt/download/support/guide2006.pdf
   Google Scholar
• National Center for AIDS/STD Control and Prevention. (2011). Progress of the methadone maintenance treatment program in China [powerpoint slides]. Retrieved March 13, 2013, from http: //www.chinaids.org.cn/n16/n716559/n716639/720173.html
   Google Scholar
• Needle, R. H. & Zhao, L. (2010). Closing the coverage gap, expanding access and scaling up HIV prevention core interventions for injection drug users in PEPFAR countries: 2009–2013. Washington, DC: Center for Strategic and International Studies
   Google Scholar
• Pang, L., Hao, Y., Mi, G., Wang, C., Luo, W., Rou, K., (2007). Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS, 21( Suppl 8), S103–107. doi: 10.1097/01.aids.0000304704.71917.6400002030-200712008-00016 [pii]
   PubMed Web of Science ®Google Scholar
• Peles, E., Kreek, M. J., Kellogg, S., & Adelson, M. (2006). High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. Journal of Addictive Diseases, 25(1), 43–50.
   PubMed Web of Science ®Google Scholar
• Pollack, H. A., & D'Aunno, T. (2008). Dosage patterns in methadone treatment: Results from a national survey, 1988–2005. Health Services Research, 43(6), 2143–2163. doi: HESR870 [pii]10.1111/j.1475-6773.2008.00870.x
   Google Scholar
• Qian, H. Z., Hao, C., Ruan, Y., Cassell, H. M., Chen, K., Qin, G., (2008). Impact of methadone on drug use and risky sex in China. Journal of Substance Abuse Treatment, 34(4), 391–397. doi: S0740-5472(07)00188-2 [pii]10.1016/j.jsat.2007.07.002
   PubMed Web of Science ®Google Scholar
• Qian, H. Z., Schumacher, J. E., Chen, H. T., & Ruan, Y. H. (2006). Injection drug use and HIV/AIDS in China: Review of current situation, prevention and policy implications. Harm Reduction Journal, 3, 4. doi: 1477-7517-3-4 [pii]10.1186/1477-7517-3-4
   PubMedGoogle Scholar
• Rhoades, H. M., Creson, D., Elk, R., Schmitz, J., & Grabowski, J. (1998). Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. American Journal of Public Health, 88(1), 34–39.
   PubMed Web of Science ®Google Scholar
• Serpelloni, G., Carrieri, M. P., Rezza, G., Morganti, S., Gomma, M., & Binkin, N. (1994). Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care, 6(2), 215–220. doi: 10.1080/09540129408258632
   PubMed Web of Science ®Google Scholar
• Shahriar, J., Delate, T., Hays, R. D., & Coons, S. J. (2003). Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health and Quality of Life Outcomes , 1, 25. doi: 10.1186/1477-7525-1-25
   PubMedGoogle Scholar
• Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial. JAMA, 281(11), 1000–1005. doi: joc81302 [pii]
   PubMed Web of Science ®Google Scholar
• van Ameijden, E. J., van den Hoek, J. A., van Haastrecht, H. J., & Coutinho, R. A. (1992). The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. American Journal of Epidemiology, 136(2), 236–243.
   PubMed Web of Science ®Google Scholar
• Wang, W., Lopez, V., Ying, C. S., & Thompson, D. R. (2006). The psychometric properties of the Chinese version of the SF-36 health survey in patients with myocardial infarction in mainland China. Quality of Life Research, 15(9), 1525–1531. doi: 10.1007/s11136-006-0012-1
   PubMedGoogle Scholar
• Ware, J. E., Kosinski, M., Turner-Bowker, D. M. & Gandek, B. (2002). How to score version 2 of the SF-12® health survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric Incorporated.
   Google Scholar
• Williams, A. B., McNelly, E. A., Williams, A. E., & D'Aquila, R. T. (1992). Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care, 4(1), 35–41.
   PubMed Web of Science ®Google Scholar
• World Health Organization (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organization; Retrieved March 13, 2013, from http://whqlibdoc.who.int/publications/ 2009/9789241547543_eng.pdf
   Google Scholar
• Wu, A. W., Hays, R. D., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6(6), 531–554.
   PubMedGoogle Scholar
• Xiao, L., Wu, Z., Luo, W., & Wei, X. (2010). Quality of life of outpatients in methadone maintenance treatment clinics. J Acquired Immune Deficiency Syndrome, 53( Suppl 1), S116–120. doi: 10.1097/QAI.0b013e3181c7dfb500126334-201002011-00020 [pii]
   PubMedGoogle Scholar